rs56217512

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001382430.1(AKT1):​c.9C>T​(p.Asp3Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,611,060 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 2 hom. )

Consequence

AKT1
NM_001382430.1 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.67

Publications

4 publications found
Variant links:
Genes affected
AKT1 (HGNC:391): (AKT serine/threonine kinase 1) This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
AKT1 Gene-Disease associations (from GenCC):
  • Proteus syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 6
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 14-104792635-G-A is Benign according to our data. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104792635-G-A is described in CliVar as Likely_benign. Clinvar id is 473867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.67 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000985 (15/152266) while in subpopulation EAS AF = 0.00251 (13/5174). AF 95% confidence interval is 0.00149. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 15 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKT1NM_001382430.1 linkc.9C>T p.Asp3Asp synonymous_variant Exon 3 of 15 ENST00000649815.2 NP_001369359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKT1ENST00000649815.2 linkc.9C>T p.Asp3Asp synonymous_variant Exon 3 of 15 NM_001382430.1 ENSP00000497822.1 P31749-1

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152148
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00251
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000362
AC:
9
AN:
248402
AF XY:
0.0000296
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000234
AC:
342
AN:
1458794
Hom.:
2
Cov.:
32
AF XY:
0.000222
AC XY:
161
AN XY:
725866
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33476
American (AMR)
AF:
0.0000447
AC:
2
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00768
AC:
305
AN:
39692
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50548
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000270
AC:
30
AN:
1111864
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000985
AC:
15
AN:
152266
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41550
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00251
AC:
13
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67994
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000491
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Mar 16, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Cowden syndrome 6 Benign:1
Oct 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
15
DANN
Benign
0.97
PhyloP100
2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56217512; hg19: chr14-105258972; API